3 Dividends Investors Love

This video features Sanofi, Bristol-Myers Squibb, and Teva. Max Macaluso has no position in any stocks mentioned, and neither does The Motley Fool.

Three dividend-paying pharmaceutical stocks -- Sanofi (NYSE: SNY  ) , Bristol-Myers Squibb (NYSE: BMY  ) , and Teva (NYSE: TEVA  ) -- have earned the much-coveted five-star rating from The Motley Fool CAPS community. However, are all of these stocks well positioned for growth? Are Sanofi and Bristol-Myers Squibb's top lines still hurting from patent expirations? Does Teva have significant challenges ahead? Analyst Max Macaluso offers his opinion on these three stocks in the following video.

The wisdom of Warren Buffett

Warren Buffett has made billions through his investing and he wants you to be able to invest like him. Through the years, he has offered up investing tips to shareholders of Berkshire Hathaway. Now you can tap into the best of Warren Buffett's wisdom in a new special report from The Motley Fool. Click here now for a free copy of this invaluable report.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2657396, ~/Articles/ArticleHandler.aspx, 9/1/2014 10:32:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement